Smofkabiven 12.7 g

SMOFKABIVEN 12.7 G is an intravenous emulsion containing dextrose, designed for nutritional support. This product, manufactured by Fresenius Kabi Canada Ltd, provides essential calories and energy for patients requiring parenteral nutrition.

SMOFKABIVEN 12.7 G is primarily used for nutritional support in patients who cannot consume food orally. This intravenous emulsion provides calories and energy, making it suitable for individuals with malabsorption issues or those recovering from surgery. It is often used in clinical settings to maintain proper nutrition levels when oral intake is not possible.

When administered intravenously, SMOFKABIVEN 12.7 G provides a source of energy and essential nutrients. Patients may experience improved energy levels and overall well-being as the emulsion supports their nutritional needs. However, individual responses can vary, and it is important to monitor for any adverse effects.

SMOFKABIVEN 12.7 G should be administered under medical supervision to ensure proper dosage and monitoring. Patients with certain medical conditions, such as diabetes or metabolic disorders, should use this product with caution. Always follow the guidelines provided by healthcare professionals to minimize potential risks.

SMOFKABIVEN 12.7 G may interact with other medications or supplements, particularly those affecting blood sugar levels. It is important to inform healthcare providers about all current medications to avoid potential interactions. Additionally, alcohol and certain dietary supplements may influence the effectiveness of this emulsion.